Evidence map›Paper›PMID 33431651›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation.

Daniel Giovinazzo, Biljana Bursac, Juan I Sbodio, Sumedha Nalluru, Thibaut Vignane, Adele M Snowman, Lauren M Albacarys, Thomas W Sedlak, Roberta Torregrossa, Matthew Whiteman and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 2 pooled it
23.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 2 syntheses or guidelines pooled it, 251 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. The microbiota-proteostasis axis: implications in neurodegenerative diseases.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  7. Review
  8. Catechol-Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Distinct single-nucleus RNA-seq changes among non-neuronal cells in ADNC, LATE-NC, and mixed pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Daniel GiovinazzoThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.ORCID https://orcid.org/0000-0002-3655-6460
Biljana BursacLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., 44227 Dortmund, Germany.
Juan I SbodioThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Sumedha NalluruThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.ORCID https://orcid.org/0000-0003-0921-047X
Thibaut VignaneLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., 44227 Dortmund, Germany.ORCID https://orcid.org/0000-0002-3377-3187
Adele M SnowmanThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Lauren M AlbacarysThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Thomas W SedlakDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Roberta TorregrossaUniversity of Exeter Medical School, EX1 2LU Exeter, United Kingdom.ORCID https://orcid.org/0000-0002-1809-7029
Matthew WhitemanUniversity of Exeter Medical School, EX1 2LU Exeter, United Kingdom.ORCID https://orcid.org/0000-0002-6583-6779
Milos R FilipovicLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., 44227 Dortmund, Germany.
Solomon H SnyderThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205; ssnyder@jhmi.edu bpaul8@jhmi.edu.
Bindu D PaulThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205; ssnyder@jhmi.edu bpaul8@jhmi.edu.ORCID https://orcid.org/0000-0002-1862-6103
Johns Hopkins University · USLeibniz Institute for Analytical Sciences - ISAS · DEUniversity of Exeter · GB

Funding

Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Thorase Regulation of the Actions of CocaineP50DA044123 · NIDA · JOHNS HOPKINS UNIVERSITY · PI DAWSON, VALINA L., JANAK, PATRICIA H. · 2018 to 2022
$9.0M
Medical Research Council MR/S002626/1NIDA NIH HHS P50 DA044123NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

Alzheimer's disease (AD), the most common cause of dementia and neurodegeneration in the elderly, is characterized by deterioration of memory and executive and motor functions. Neuropathologic hallmarks of AD include neurofibrillary tangles (NFTs), paired helical filaments, and amyloid plaques. Mutations in the microtubule-associated protein Tau, a major component of the NFTs, cause its hyperphosphorylation in AD. We have shown that signaling by the gaseous molecule hydrogen sulfide (H

Indexed as

Alzheimer DiseaseAnimalsCystathionine gamma-LyaseDisease Models, AnimalGlycogen Synthase Kinase 3 betaHEK293 CellsHippocampusHumansHydrogen SulfideMiceMice, TransgenicMorpholinesMutationNeurofibrillary TanglesNeuroprotective AgentsOrganothiophosphorus CompoundsCystathionine gamma-LyaseGlycogen Synthase Kinase 3 betaGYY 4137Hydrogen SulfideMAPT protein, humanMapt protein, mouseMorpholinesNeuroprotective AgentsOrganothiophosphorus CompoundsSulfatestau ProteinsAlzheimer’s diseaseGSK3betahydrogen sulfidesulfhydrationTau

Identifiers

PMID33431651
PMCPMC7848711
OpenAlexW3120036520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.